Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs. (Q51795427)
Jump to navigation
Jump to search
scientific article published on 9 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs. |
scientific article published on 9 August 2007 |
Statements
Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs (English)
Adrienne E Dubin
Anindya Bhattacharya
Brian P Scott
Nadia Nasser
Hong Ao
Devin M Swanson
Nigel P Shankley
Alan D Wickenden
Sandra R Chaplan